In particular, increased IFIT1 and IFIT3 expression has been correlated with improved therapeutic response to chemotherapeutics and immunostimulating agents [69, 70] and increased IFIT2 expression in the tumour tissues of patients was associated with improved patient survival [71]. Here, IFIT2 is linked to neoplasm.